Presence of functional type B natriuretic peptide receptor in human ocular cells

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 9, 1996, Pages 1724-1731

  Pang, Iok Hou ^a,c   Shade, Debra L ^a   Matsumoto, Shun ^a,b   Steely, H Thomas ^a   DeSantis, Louis ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b TOKYO TEISHIN HOSPITAL   (Japan)

^c Alcon Research Laboratories   (United States)

Author keywords

ciliary muscle; cyclic guanosine monophosphate; natriuretic peptide; NPR B; trabecular meshwork

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CALCIUM; CARBACHOL; CYCLIC GMP; GUANYLATE CYCLASE; HORMONE RECEPTOR; ISOBUTYLMETHYLXANTHINE; NATRIURETIC FACTOR RECEPTOR; NATRIURETIC PEPTIDE TYPE C; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CELL CULTURE; CILIARY MUSCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIMIAN VIRUS 40; TRABECULAR MESHWORK; VIRUS CELL TRANSFORMATION;

1-METHYL-3-ISOBUTYLXANTHINE; ATRIAL NATRIURETIC FACTOR; CALCIUM; CARBACHOL; CELL LINE, TRANSFORMED; CELLS, CULTURED; CILIARY BODY; CYCLIC GMP; GUANYLATE CYCLASE; HUMANS; INTRAOCULAR PRESSURE; KINETICS; MUSCLE CONTRACTION; NATRIURETIC PEPTIDE, C-TYPE; PROTEINS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIMIAN VIRUS 40; TRABECULAR MESHWORK;

EID: 0029841907     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Becker B. Topical 8-bromo-cyclic GMP lowers intraocular pressure in rabbits. Invest Ophthalmol Vis Sci. 1990;31:1647-1649.
2. Stein PJ, Clack JW. Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits. Invest Ophthalmol Vis Sci. 1994;35:2765-2768.
3. Nathanson JA. Direct application of a guanylate cyclase activator lowers intraocular pressure. Eur J Pharmacol. 1988;147:155-156.
4. Nathanson JA. Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther. 1992; 260:956-965.
5. Kee C, Kaufman PL, Gabelt BT. Effect of 8-Br cGMP on aqueous humor dynamics in monkeys. Invest Ophthalmol Vis Sci. 1994;35:2769-2773.
6. Schuman JS, Erickson K, Nathanson JA. Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys. Exp Eye Res. 1994;58:99-105.
7. Wiederholt M, Sturm A, Lepple-Wienhues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci. 1994;35:2515-2520.
8. Goh Y, Hotehama Y, Mishima HK. Characterization of ciliary muscle relaxation induced by various agents in cats. Invest Ophthalmol Vis. Sci. 1995;36:1188-1192.
9. Matsumoto S, DeSantis L, Pang I-H. Receptor mediated nucleotide cyclases stimulation in cultured non-transformed and transformed human ciliary muscle cells. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1993;34:1045.
10. Pang I-H, Shade DL, Clark AF, Steely HT, DeSantis L. Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr Eye Res. 1994;13:51-63.
11. DrewettJG, Garbers DL. The family of guanylyl cyclase receptors and their ligands. Endocrine Rev. 1994; 15:135-162.
12. Koller KJ, Lowe DG, Bennett GL, et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991;252:120-123.
13. Nathanson JA. Atriopeptin-activated guanylate cyclase in the anterior segment: Identification, localization, and effects of atriopeptins on IOP. Invest Ophthalmol Vis Sci. 1987;28:1357-1364.
14. Mittag TW, Tormay A, Ortega M, Severin C. Atrial natriuretic peptide (ANP), guanylate cyclase, and intraocular pressure in the rabbit eye. Curr Eye Res. 1987;6:1189-1196.
15. Sugrue MF, Viader M-P. Synthetic atrial natriuretic factor lowers rabbit intraocular pressure. Eur J Pharmacol. 1986;130:349-350.
16. Korenfeld MS, Becker B. Atrial natriuretic peptides: Effects on intraocular pressure, cGMP, and aqueous flow. Invest Ophthalmol Vis Sci. 1989;30:2385-2392.
17. Lehman NL, Chang AT, Nguyen TD, Polansky JR, Crook RB. Atrionatriuretic peptide receptors on human trabecular meshwork cells. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1994;35:2053.
18. Tamm E, Flügel C, Baur A, Lütjen-Drecoll E. Cell cultures of human ciliary muscle: Growth, ultrastructural and immunocytochemical characteristics. Exp Eye Res. 1991;53:375-387.
19. Steely HT, Browder SL, Julian MB, Miggans ST, Wilson KL, Clark AF. The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1992; 33:2242-2250.
20. Danziger RS, Star RA, Matsumoto S, Coca-Prados M, DeSantis L, Pang I-H. Characterization of soluble guanylyl cyclase in transformed human nonpigmented epithelial cells. Biochem Biophys Res Comm. 1993; 195:958-962.
21. Shade DL, Clark AF, Pang I-H. Effects of muscarinic agents on human trabecular meshwork cell functions. Exp Eye Res. 1996;62:201-210.
22. ++ indicators with greatly improved fluorescent properties. J Biol Chem. 1985;260:3440-3450.
23. Kobayashi S, Kanaide H, Nakamura M. Cytosolic-free calcium transients in cultured vascular smooth muscle cells: Microfluorometric measurements. Science. 1985; 229:553-556.
24. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem. 1989;264:1146-1155.
25. Matsumoto S, Yorio T, DeSantis L, Pang I-H. Muscarinic effects on cellular functions in cultured human ciliary muscle cells. Invest Ophthalmol Vis Sci. 1994; 35:3732-3738.
26. Light DB, Schwiebert EM, Karlson KH, Stanton BA. Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science. 1989;243:383-385.
27. Stanton BA. Molecular mechanisms of ANP inhibition of renal sodium transport. Can J Physiol Pharmacol. 1991;69:1546-1552.
28. Carre DA, Civan MM. cGMP modulates transport across the ciliary epithelium. ARVO Abstract. Invest Ophthalmol Vis Sci. 1995;36:S590.
29. Hassid A. Atriopeptin II decreases cytosolic free Ca in cultured vascular smooth muscle cells. Am J Physiol. 1986;251:C681-C686.
30. 2+ exchange in vascular smooth muscle cells in primary culture. J Biol Chem. 1991;266:12337-12341.
31. Popescu LM, Panoiu C, Hinescu M, Nutu O. The mechanism of cGMP-induced relaxation in vascular smooth muscle. Eur J Pharmacol. 1985;107:393-394.
32. ++ by sarcoplasmic reticulum in vascular smooth muscle. Circ Res. 1988;62:961-964.
33. 2+ pump of smooth muscle via phosphorylation of phosphatidylinositol. Biochem J. 1988;255:855-863.
34. Maack T, Kleinert HD. Renal and cardiovascular effects of atrial natriuretic factor. Biochem Pharmacol. 1986;35:2057-2064.
35. Stingo AJ, Clavell AL, Aarhus LL, Burnett JC. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol. 1992;262:H308-H312.
36. Wei CM, Aarhus LL, Miller VM, Burnett JC. Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol. 1993;264:H71-H73.
37. Takashima Y, Yoshida M, Yoshimura N, Honda Y. Effects of natriuretic peptide family on intraocular pressure of rabbit eyes. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1995;36:S734.